The method for "Determination of Total Folates in Infant Formula and Adult Nutritionals by Trienzyme Extraction and UPLC-MS/MS Quantitation" was submitted to the Folate Working Group for consideration for adoption as Offi cial First Action by AOAC INTERNATIONAL. This method uses ultra performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) to determine the total folates in infant formulas and adult nutritionals after trienzyme digestion. Deconjugation of the various folate polyglutamates to folate monoglutamates is achieved by using rat plasma conjugase after the sample digestion with protease and α-amylase during the trienzyme digestion process. This method shows linearity of folate concentrations in the range of 10-19 100 μg/100 g. Extension of the range to cover folate concentrations of 5-2 000 000 μg/100 g can be achieved with appropriate adjustment of the sample weight and SPE cleanup loading volume. The recoveries ranged from 94.10 to 101.34%.
F
olates play an important role in good health. Because of this, it has become increasingly necessary to have reliable and accurate methods for determining the levels of total folates in infant formula and adult nutritionals. The method for the "Determination of Total Folates in Infant Formula and Adult Nutritionals by Trienzyme Extraction and UPLC-MS/MS Quantitation" has been submitted as a suitable alternative to microbiological assay methods, which are time-consuming and relatively complex.
After supporting data on this method were collected, the information was reviewed by an Expert Review Panel (ERP). After the review was completed, the ERP, based upon the currently available validation data, decided that this method should be adopted as an AOAC Offi cial First Action method. The method was adopted under the AOAC Board of Directors-approved alternative pathway. This process allows the method to be used by laboratories for approximately 2 years to gather additional information. The information will be reviewed along with any feedback provided on the method in order for the ERP to decide if the method can be recommended to the AOAC Offi cial Methods Board for Final Action status (1).
AOAC Offi cial Method 2011.06 Total Folates in Infant Formula and Adult Nutritionals Trienzyme Extraction and UPLC-MS/MS Quantitation First Action 2011
(Applicable to the determination of folate content of infant formula and adult nutritionals.)
A. Principle
A homogenized sample is accurately weighed into a 50 mL centrifuge tube. An appropriate amount of internal standard (IS) and phosphate buffer, pH 6, are added. The sample is placed in a shaker bath set at 50°C to disperse the matrix. α-Amylase and protease enzymes are added to further break down the matrix for extraction of the folates. Rat plasma conjugase is used to deconjugate the polyglutamate forms of folates to monoglutamates. The sample is centrifuged and the supernatant is fi ltered through a 0.45 μm fi lter. The fi ltrate is cleaned using weak anion exchange (WAX) SPE. The folates are eluted into methanol containing 10% formic acid and 1% ascorbic acid and analyzed by UPLC-MS/MS. Six folate vitamers are quantifi ed and the total folates determined and expressed as folic acid. Isotopically labeled folic acid ( 13 C-folic acid) is used as the IS. , 6, 7, .
B. Apparatus and Materials
(d) (6S) 6, 7, .
(e) (6S) 6, 7, (2) In a fume hood, slowly add approximately 700 mL DI water and approximately 4.8 mL glacial acetic acid.
(3) Add 250 g ascorbic acid and 10 mL 2-mercaptoethanol. Stir to completely dissolve using a stir bar. Add concentrated ammonium hydroxide dropwise as necessary to dissolve completely.
(4) Check the pH of the solution and adjust to pH 5.5, if necessary, using concentrated ammonium hydroxide or glacial acetic acid. (The ratio of ammonium acetate:glacial acetic acid will give a pH close to 5.5 but the ascorbic acid addition will lower the pH.) (5) Transfer solution into a 1 L volumetric fl ask and bring to volume with DI water.
(b) Folate intermediate standard solution solvent.-10 mM ammonium acetate buffer with 1% ascorbic acid, pH 5.5.
(1) Weigh approximately 1.2 g ammonium acetate and transfer into a 1000 mL beaker (use DI water to completely transfer if necessary).
(2) In a fume hood, add approximately 700 mL DI water and approximately 4.8 mL glacial acetic acid. Add 10 g ascorbic acid and stir until completely dissolved.
(3) Adjust the pH to 5.5 if necessary with concentrated ammonium hydroxide or glacial acetic acid. (1) Into a 100 mL volumetric fl ask, transfer 10 mL formic acid and 1 g ascorbic acid. Add approximately 50 mL methanol.
(2) Sonicate in a water bath set at approximately 25°C until complete dissolution.
(3) Bring to volume with methanol. Use solution to elute folates from SPE sorbent after cleanup, to make analytical standard of folates, and as a blank in UPLC-MS/MS analysis. (1) Prepare a 100 mL internal standard solution such that the IS concentration is 50 μg/mL. The amount of internal standard stock solution to add to the 100 mL low-actinic volumetric fl ask is determined using the following equation:
Volume of internal standard stock solution to pipet into fl ask, mL =100 mL × (50 μg/mL  internal standard stock solution concn, μg/mL) (1) Prepare a 100 mL rat plasma conjugase test solution such that the conjugase concentration is 20 μg/mL. The amount of conjugase stock solution to add to the 100 mL low-actinic volumetric fl ask is determined using the following equation:
Volume of conjugase stock solution to pipet into fl ask, mL = 100 mL × (20 μg/mL  pteroyltri-γ-glutamic acid stock solution concn, μg/mL) (k) Rat plasma conjugase.-(1) The rat plasma is received from the supplier frozen in a vessel containing lithium/heparin anticoagulant. Allow the rat plasma to thaw in a fume hood.
(2) Transfer into 50 mL centrifuge tubes (nonsterile) and centrifuge at 5500 rpm (7280 g) for 20 min at 4°C.
(3) Transfer the supernatant in 4 mL portions into 15 mL centrifuge tubes for storage. Immediately cover and store in the freezer at -70°C.
(4) During analysis, only the amount of conjugase to be used should be thawed. Avoid thawing and refreezing the conjugase as much as possible.
(5) At 3-month intervals, check the viability of the rat plasma conjugase by deconjugating folic acid polyglutamates to folic acid monoglutamates. See F(b) and G(c) for detail instructions.
(6) The viability of the rat plasma conjugase, expressed as the percent conversion of 3 μg pteroyltri-γ-L-glutamate (FA-glu 3 ) to folic acid, must be ≥95% in order for the rat plasma to be used.
(l) Extraction buffer.-10 mM phosphate buffer, 1% ascorbic acid, pH 6.0.
(1) Accurately weigh and transfer approximately 1.4 g sodium phosphate, dibasic, anhydrous (Na 2 HPO 4 ) into a 1000 mL beaker. Add 10 g ascorbic acid (sodium ascorbate) and approximately 700 mL DI water. Stir on a stir plate until completely dissolved.
(2) Adjust the pH with phosphoric acid and/or 10 M sodium hydroxide (NaOH) to pH 6.0.
(3) Transfer into a 1000 mL volumetric fl ask and bring to volume with DI water. Prepare fresh on the day of use.
(m) UPLC mobile phase.-10 mM ammonium formate buffer, pH 2.8.
(1) Accurately weigh 70.5 mg ammonium formate and transfer into a 1000 mL beaker. Add approximately 700 mL DI water and stir on stir plate to dissolve. Note: Do not exceed 10 mM ammonium formate as this may adversely affect mass spectrometer performance.
(2) Adjust the pH to 2.8 with formic acid or ammonium hydroxide.
(3) Transfer into a 1000 mL volumetric fl ask and bring to volume with DI water. Filter through a 0.22 μm fi lter into the mobile phase reservoir. Empty and rinse container (do not wash with detergent) and prepare fresh every 30 days.
E. Sample Preparation
(a) Make sure that all samples are completely homogenized before weighing (see Table 2011 .06A).
(b) Prepare the rat plasma conjugase as described in D(k).
F. Procedure
(a) Using Table 2011 .06A, weigh the appropriate amount of homogenized sample, reference material (RM), or NIST standard reference material (SRM) into a 50 mL centrifuge tube using an analytical balance and accurately record the weight. Add one additional 50 mL centrifuge tube containing no sample as an enzyme blank.
(1) Add 100 μL of the 50 μg/mL internal standard intermediate solution [to give 5 μg 13 C-folic acid (IS) in the sample] to each centrifuge tube.
(2) Add 10 mL extraction buffer (10 mM phosphate buffer, pH 6.0, containing 1% ascorbic acid). Vortex to mix well.
(3) Shake in a water bath set at 50°C for 30 min and then cool to room temperature.
(b) To check the effi cacy of the rat plasma conjugase, use 150 μL rat plasma test solution (20 μg/mL pteroyltri-γ-glutamate) in place of the homogenized sample in the 50 mL centrifuge tube.
(1) Add 100 μL of the 50 μg/mL internal standard intermediate solution [to give 5 μg 13 C-folic acid (IS) in the sample]. Add 10 mL extraction buffer (10 mM phosphate buffer, pH 6.0, containing 1% ascorbic acid). Vortex to mix well.
(2) Shake in a water bath set at 50°C for 30 min. Cool to room temperature.
(c) Add 1 mL protease solution to each centrifuge tube, cover, vortex to mix, and incubate for 3 h in a water bath set at 37°C.
(d) Inactivate the protease enzyme by placing the samples in a boiling water bath (100°C) for approximately 5 min with shaking. After inactivating the enzyme, cool the samples to room temperature.
(e) Add 1 mL -amylase solution to each centrifuge tube and incubate in water bath set at 37°C for 2 h.
(f) Add 300 μL rat plasma conjugase to each centrifuge tube, cover, and incubate for 22 h in water bath set at 37°C. Table 2011 .06A for appropriate amount of supernatant to fi lter.) Repeat for each sample, taking care to fi lter samples into the wells in order.
(j) Set up the Connect the manifold to the low-vacuum system.
(2) Place a waste reservoir in the unit (see instruction manual).
(k) Condition the SPE sorbent.-(1) Add 1 mL methanol to each well (use a 12-tip pipet or a robotic pipetting unit if available).
(2) Turn on the low-vacuum unit and allow the conditioning solvent (methanol) to elute at a rate of approximately 2-5 mL/min.
(3) Repeat with an additional 1 mL methanol. (4) Before the SPE sorbent is completely dry, repeat the process with water (2 mL in 1 mL portions).
(5) Before the sorbent is completely dried of solvent, turn off the vacuum by completely opening the control valve on the manifold (refer to manifold's manual).
(l) Take care to avoid the sorbent being completely dry of solvent for a protracted period of time. Check and empty the waste reservoir frequently to avoid overfl owing. (2) Load each well with 2 mL solvent for SPE elution and folates standard (methanol containing 10% formic and 1% ascorbic acid).
(3) Allow gravity to elute the eluent into the receiving vessel. (Very low vacuum may be applied to facilitate elution, but do not exceed 1 mL/min fl ow.) (p) When elution is complete, turn off the low-vacuum pump and remove the 96-well receiving vessel from the manifold.
(q) Transfer the eluent in the wells into vials for UPLC-MS/MS analysis (take care to properly label the samples when tranferring into vials). Label one vial "standard" and fi ll with folate analytical standard solution. Label one vial "blank" and fi ll with solvent for SPE elution and folates standard (methanol with 10% formic acid and 1% ascorbic acid). Prepare two vials for the RM (or NIST SRM 1846). The fi rst vial is run at the start of the run and the second is a check at the end of the run.
(r) Prepare the UPLC system and mass spectrometer for analysis.-(1) Refer to supplemental information (preparing and running UPLC-MS/MS).
(2) Load the autosampler in the UPLC autosampler with the vials from F(q).
(s) Analyze the samples using the instrumental methods (see Tables 2011.06B -E for details).
(t) Check that all peaks are marked correctly and that the IS peak areas do not show interference (IS peak areas similar to IS peak areas of RM or NIST control samples). Rerun sample weighing up less sample if interference is suspected. where F = RF for the analyte using a specifi c mass spectral daughter ion (see Table 2011 .06E); PA 1 = peak area of IS in the standard solution; PA 2 = peak area of analyte daughter ion in the standard solution; C 1 = concentration of IS in the standard solution; C 2 = concentration of analyte in the standard solution; W = measured water fraction as determined by Karl Fisher, %; S = calcium fraction in Ca salt folate standard, % (see Note); and H i = vendor-stated dry weight basis of analyte i as stated on the Certifi cate of Analysis (% HPLC purity).
G. Calculations
Note: Only applicable for 5-formyltetrahydrofolate and 5-methyltetrahydrofolate. Percent Ca salt is 7.84 and 8.06%, respectively. % Ca = formula weight (FW) Ca  FW Ca folate salt × 100.
(b) Determine the concentration (μg/100 g) of folate vitamer in the sample as follows (concentrations are calculated for each daughter ion using corresponding response factors):
where C = concentration in μg/100 g folate vitamer in the sample; PA 2 = peak area of folate vitamer in the sample chromatogram; PA 1 = peak area of the IS in the sample chromatogram; W 1 = weight, in μg, of IS added to the sample before extraction; W 2 = weight, in grams, of the sample; F = RF of folate vitamers using corresponding daughter ions from where C fa = concentration in g/100 g folate vitamer in sample expressed as folic acid; PA 2 = peak area of folate vitamer in sample chromatogram; PA 1 = peak area of internal standard in sample chromatogram; W 1 = weight, in g, of internal standard added to sample before extraction; W 2 = weight, in grams, of sample; F = RF of folate vitamers from calculation, G(a); 100 = conversion of concentration of folate vitamers to g/100 g. where PA (FA) = peak area of folic acid peak after conversion reaction; PA (IS) = peak area of IS peak after conversion reaction; μg (IS) = μg IS added; F = RF for folic acid from G(a); 441.3 = formula weight of folic acid in μg/μmole used to convert μg of recovered folic acid to μmoles for comparison; 0.0042882 = μmoles of pteroyltri-γ-glutamate (FA-glu 3 ) obtained from converting the μg of "rat plasma test solution" to μmoles for comparison, i.e., 0.15 mL × 20 μg/mL/699.2 μg/μmoles; 699.2 μg/μmoles is the formula weight of FA-glu 3 ; 100 = conversion to percent. 
Results and Discussion

System Linearity Study
Standards of folates expressed as FA with known amounts of internal standard were analyzed by the method. The standards were not taken through the extraction process, only the UPLC-MS/MS procedure was performed to determine the linear range of the instrument's response. The following plots illustrate the instrument's response with increased analyte concentration.
A plot of the peak area ratios (PA-Folates/PA-IS) versus the concentration showed a linear relationship between 0.01 and 100 μg/mL (ppm) with R 2 of 0.9941 (Figure 1) . A further plot of the response factors versus folates concentration showed linearity at 95% confi dence level between 0.025 and 95.5 μg/mL. Express as μg/100 g to 19 100 μg/100 g. The LOD of total folates by this method defi ned as three times the SD of the blank is 0.01 μg.mL. This would correspond to 2 μg/100 g of total folates for a sample weight of 1 g with 2 μL injection on the analytical column. But the linear response of the instrument to concentration is between 10.0 μg/100 g and 191 000 μg/100 g for a sample weight of 1 g with 2 μL injection onto the analytical column. Therefore, the method's detection limit is 10 μg/100 g for a 1 g sample weight with 2 μL injection volume on the analytical column. The detection limit can be reduced to 5 μg/100 g when the sample weight is increased to 2 g.
Accuracy
Accuracy estimation was obtained by running a study using four spiked matrixes. The samples used were NIST 1846 (infant formula), NIST 3244 (protein powder containing ephedra), multigrain cereal, and milk-based yogurt beverage. These samples were spiked with folic acid at four levels each. The recovery percentages were calculated by using the slope of the regression lines compared to equivalent spikes. See Table 1 for the results of the spiking recovery study.
Precision
An estimation of the precision was obtained by replicate analyses. The design of this testing included 12 different matrix samples run in triplicate over a 5 day span by one analyst. The results and the data analysis can be found in Tables 2 and 3 , respectively. The relationship between variation and analyte level was established by plotting the SD as a function of the average of each sample studied. The intercept was obtained by using weighted least squares regression (weight = 1/average). This intercept estimation was determined not to be signifi cantly different from zero (P <0.05) with a slope of 0.099. From this, the performance was demonstrated to be at constant CV through the range tested with the CV estimation being 9.9% RSD. 
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